Arcturus therapeutics to present at jefferies london healthcare conference

San diego--(business wire)---- $arct #clinicaltrial--arcturus therapeutics holdings inc. (the “company”, “arcturus”, nasdaq: arct), a commercial messenger rna medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the company will present at jefferies london healthcare conference in london, on wednesday, november 20, 2024, at 9:30 am gmt. a webcast and replay of the presentation will be available on the investor rela.
ARCT Ratings Summary
ARCT Quant Ranking